Deborah L Zimmerman

age ~63

from Livermore, CA

Get Report

Also known as:

Zimmerman Deborah

Phone and address:: 769 Vinci Way, Livermore, CA 94550

Connected to:

Deborah Zimmerman Phones & Addresses

769 Vinci Way, Livermore, CA 94550
Lexington, KY
8180 War Glory Pl, Pleasanton, CA 94566
3770 Las Positas Blvd, Pleasanton, CA 94588
3388 Lubich Dr, Mountain View, CA 94040
Alameda, CA
Los Altos, CA

Resumes

Physician Assistant At Ccom-Frisco

view source

Position:

Physician Assistant at Centura Centers for Occupational Medicine

Location:

Frisco, Colorado

Industry:

Hospital & Health Care

Work:

Centura Centers for Occupational Medicine - Frisco Colorado since Nov 2010
Physician Assistant
Summit Community Care Clinic Nov 2006 - Nov 2010
Physician Assistant

Education:

Duke University School of Medicine
MHS PA-C

Deborah Zimmerman

view source

Location:

United States

Medicine Doctors

Deborah M. Zimmerman

view source

Specialties:

Occupational Medicine, Physical Medicine & Rehabilitation

Work:

Centura Health Physician GroupCentura Centers For Occupational Medicine Frisco
18 School Rd STE 125, Copper Mountain, CO 80443
(970)6682510 (phone), (970)6682511 (fax)

Languages:

English

Description:

Ms. Zimmerman works in Frisco, CO and specializes in Occupational Medicine and Physical Medicine & Rehabilitation.

Deborah Celia Zimmerman

view source

Specialties:

Internal Medicine

Education:

University of Missouri at Columbia (1983)

Name / Title

Company / Classification

Phones & Addresses

Deborah S Zimmerman

PRIORITY PLUS TAX SERVICE LLC

Deborah Zimmerman
President

KHADRA INTERNATIONAL DANCE THEATRE

5809 Msn St, San Francisco, CA 94112
1182 Market St, San Francisco, CA 94102

Us Patents

Methods Of Modulating Metastasis And Skeletal Related Events Resulting From Metastases
view source
US Patent:

20080241067, Oct 2, 2008
Filed:

May 12, 2004
Appl. No.:

10/556765
Inventors:

Deborah Lee Zimmerman - Oakland CA, US
Rhonda Hansen - Richmond CA, US
Jill Winter - Richmond CA, US
Christoph Reinhard - Indiana CA, US
Shuling Fang - Castro Valley CA, US
International Classification:

A61K 49/00
A61K 39/395
A61K 31/66
C12N 5/06
C12Q 1/70
A61K 31/7088
C12P 21/00
A61K 45/00
C07H 21/04
C12Q 1/02
C12N 5/08
A61P 35/00
A61P 43/00
US Classification:

424 92, 4241301, 514141, 4241331, 4241351, 4241411, 435366, 424 91, 435 29, 435326, 536 231, 435 5, 424 937, 435 711, 514 44
Abstract:

The invention provides, inter alia, models of bone metastasis, methods for identifying agents that modulate skeletal related events and metastasis, methods for modulating skeletal related events and metastases, and methods for detecting skeletal related events and metastases. The methods and models generally comprise co-culturing cancer cells and host cells and comparing biological markers from such co-cultured cells to control cells.

M-Csf Specific Monoclonal Antibody And Uses Thereof
view source
US Patent:

20090324604, Dec 31, 2009
Filed:

Jan 6, 2005
Appl. No.:

10/585459
Inventors:

Cheng Liu - Emeryville CA, US
Deborah Lee Zimmerman - Emeryville CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - Emeryville CA, US
William M. Kavanaugh - Emeryville CA, US
Li Long - Lafayette CA, US
Arnold Horwitz - San Leandro CA, US
Assignee:

CHIRON CORPORATION - Emeryville CA
XOMA Technology Ltd. - Hamilton
International Classification:

A61K 39/395
C07K 16/00
A61P 35/00
A61P 19/00
US Classification:

4241451, 5303873, 53038815, 53038823
Abstract:

M-CSF-specific antibody RX1 is provided, along with pharmaceutical compositions containing antibody RX1, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Fxdy5 Modulators For Treating, Diagnosing, And Detecting Cancer
view source
US Patent:

20100154071, Jun 17, 2010
Filed:

Mar 28, 2008
Appl. No.:

12/450132
Inventors:

Abdallah Fanidi - Emeryville CA, US
Mary Jo Janatpour - Emeryville CA, US
Robert Q. To - Fremont CA, US
Deborah Zimmerman - Oakland CA, US
Assignee:

NOVARTIS AG - Basel
International Classification:

A01K 67/00
A61P 35/00
C12N 5/00
A61K 31/519
A61K 31/704
A61K 39/395
A61K 31/713
A61K 31/7088
A61K 49/00
C12Q 1/02
C12N 5/10
C12N 5/12
C07K 14/435
C07H 21/00
C07K 16/18
US Classification:

800 13, 435375, 514249, 514 34, 4241301, 514 44 R, 4241411, 4241391, 424 91, 435 29, 514 44 A, 435325, 530350, 536 235, 5303871
Abstract:

The invention provides, inter alia, methods for treating cancer, compositions for treating cancer, and methods and compositions for diagnosing and/or detecting cancer. In particular, the present invention provides compositions and methods for treating, diagnosing and detecting cancers associated with FXYD5 overexpression.

Methods Of Treating, Diagnosing Or Detecting Cancer
view source
US Patent:

20100196377, Aug 5, 2010
Filed:

Apr 12, 2007
Appl. No.:

12/296833
Inventors:

Guoying Yu - Kensington CA, US
Robert To - Fremont CA, US
Vivien Chan - Emeryville CA, US
Deborah Zimmerman - Oakland CA, US
International Classification:

A61K 39/395
A61K 31/7088
A61P 35/04
G01N 33/53
US Classification:

4241391, 514 44 R, 4241301, 4241411, 435 71
Abstract:

The invention provides, inter alia, methods for treating cancer, compositions for treating cancer, and methods and compositions for diagnosing and/or detecting cancer. In particular, the present invention provides compositions and methods for treating, diagnosing and detecting cancers associated with LIV-1 overexpression.

Methods For Preventing And Treating Cancer Metastasis And Bone Loss Associated With Cancer Metastasis
view source
US Patent:

20110091451, Apr 21, 2011
Filed:

Aug 9, 2004
Appl. No.:

10/914598
Inventors:

William M. Kavanaugh - Orinda CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
Cheng Liu - Richmond CA, US
Deborah L. Zimmerman - Oakland CA, US
International Classification:

A61K 39/395
A61P 35/00
A61P 19/08
US Classification:

4241331
Abstract:

M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.

Antibodies To Bone Morphogenic Proteins And Receptors Therefor And Methods For Their Use
view source
US Patent:

20110182904, Jul 28, 2011
Filed:

Sep 5, 2007
Appl. No.:

12/440000
Inventors:

Deborah Zimmerman - Oakland CA, US
Mark Selby - San Francisco CA, US
Mohan Srinivasan - San Jose CA, US
Alasdair Bell - Mountain View CA, US
Sujata Singh - Saratoga CA, US
Richard Theolis - Santa Cruz CA, US
Heidi N. Leblanc - Mountain View CA, US
Kyra D. Zens - San Mateo CA, US
Timothy William Sproul - Livermore CA, US
International Classification:

A61K 39/395
C07K 16/22
A61P 19/08
A61P 35/00
C12N 15/13
C12N 15/63
C12N 5/00
C12P 21/08
US Classification:

4241451, 53038823, 5303873, 5303911, 5303917, 5303913, 536 2353, 4353201, 435325, 435 696, 800 4
Abstract:

The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, which specifically bind to BMP2, BMP4, BMPR1A, BMPR1B, ACTR1, and/or BMPR2 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Also provided are immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention and, optionally, one or more additional therapeutic. The invention also provides methods for treating diseases associated with abnormal bone formation and ossification mediated by BMP2, BMP4, BMPR1A, BMPR1B, ACTR15 and/or BMPR2.

Method For Preventing And Treating Cancer Metastasis And Bone Loss Associated With Cancer Metastasis
view source
US Patent:

20120045450, Feb 23, 2012
Filed:

Aug 23, 2011
Appl. No.:

13/215683
Inventors:

William M. Kavanaugh - Orinda CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
Cheng Liu - Richmond CA, US
Deborah L. Zimmerman - Oakland CA, US
Assignee:

NOVARTIS AG - Basel
International Classification:

A61K 39/395
A61P 35/00
US Classification:

4241581
Abstract:

M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.

Method For Preventing And Treating Cancer Metastasis And Bone Loss Associated With Cancer Metastasis
view source
US Patent:

20140093492, Apr 3, 2014
Filed:

Mar 25, 2013
Appl. No.:

13/849819
Inventors:

Deborah Lee Zimmerman - Emeryville CA, US
Gregory Martin Harrowe - Emeryville CA, US
Cheng Liu - Emeryville CA, US
Kirston Koths - Emeryville CA, US
William Michael Kavanaugh - Orinda CA, US
Assignee:

NOVARTIS AG - Basel
International Classification:

A61K 39/395
US Classification:

4241331
Abstract:

M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.

News

Board selects Zimmerman

view source

Deborah Zimmerman, a former Forest Park Elementary Title One teacher, will begin her career administratively assisting Principal Lynn Romas and CCS Monday. "We spent some time with Mr. Romas this week trying to find someone with administrative ...

Barry's life deep in community

view source

In 1996 he presided over the case of Deborah Zimmerman who was the first woman in Wisconsin to face charges of attempted homicide of her baby after she drank an excessive amount of alcohol while pregnant. An appellate court overturned Barry's decision ...

Too heavy to save or be saved

view source

Dr. Deborah Zimmerman, nephrophologist and medical director of Ottawa's home hemodialysis unit worries that Aziz is running out of time. Kim's vascular access is becoming more and more difficult, and without a transplant, she's ultimately going to die ...

Zipperer Stands Behind Voter ID Law

view source

Resident Deborah Zimmerman said she supports the voter ID bill and told Zipperer she worked as a poll observer during the recent recall elections and everyone in line who was asked for an ID had one. I'm happy you passed the photo ID requirement for ...